ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 1107

$598K Total Retail Price of All Prescriptions

Rank: 289 out of 1107

520 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

80% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 6,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 3,914 1,566 S3 1 1
GABAPENTIN 347 116 2 9
ZOLPIDEM TARTRATE 298 161 3 22
LYRICA 295 116 4 83
LISINOPRIL 267 98 5 2
LEVOTHYROXINE SODIUM 260 160 6 3
SIMVASTATIN 243 80 7 5
METFORMIN HCL 225 112 8 8
CITALOPRAM HBR 220 109 9 17
ATENOLOL 218 110 10 19
RANITIDINE HCL 217 99 11 21
TIZANIDINE HCL 206 91 12 73
OMEPRAZOLE 205 86 13 4
POTASSIUM CHLORIDE 196 126 14 14
FUROSEMIDE 182 117 15 7
AMLODIPINE BESYLATE 167 103 16 6
PROMETHAZINE HCL 160 71 R 17 44
NEXIUM 157 69 18 18
METOPROLOL TARTRATE 156 75 19 10
CLONIDINE HCL 153 73 20 53
CARISOPRODOL 145 52 R 21 146
TRAMADOL HCL 139 71 22 26
HYDROCHLOROTHIAZIDE 127 64 23 11
CLOPIDOGREL 124 78 24 28
ROPINIROLE HCL 117 47 25 69
ALPRAZOLAM 113 67 26 87
BUMETANIDE 113 68 26 123
AMITRIPTYLINE HCL 112 69 R 28 48
CYCLOBENZAPRINE HCL 110 17 R 29 56
DICLOFENAC SODIUM 99 56 30 74
MELOXICAM 98 39 31 25
METOPROLOL SUCCINATE 97 63 32 16
AZITHROMYCIN 94 40 33 35
ATORVASTATIN CALCIUM 93 57 34 13
SERTRALINE HCL 89 18 35 20
PROAIR HFA 89 41 35 37
PLAVIX 87 39 37 39
SINGULAIR 87 56 37 65
METOCLOPRAMIDE HCL 87 20 37 116
SPIRONOLACTONE 82 39 40 72
IBUPROFEN 81 22 41 63
ADVAIR DISKUS 79 38 42 54
CIPROFLOXACIN HCL 76 41 43 59
CRESTOR 73 36 44 23
PRAVASTATIN SODIUM 71 27 45 12
LIDODERM 69 21 46 140
ALLOPURINOL 69 37 46 36
LOSARTAN POTASSIUM 63 25 48 29
PREMARIN 62 32 R 49 149
SYNTHROID 57 34 50 70
BACLOFEN 56 12 51 133
BISOPROLOL-HYDROCHLOROTHIAZIDE 55 33 52 164
CELEBREX 55 26 52 85
CYMBALTA 53 0 54 50
TRICOR 51 18 55 95
DONEPEZIL HCL 51 46 55 32
NASONEX 50 29 57 206
TRAZODONE HCL 50 24 57 33
JANUVIA 50 11 57 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.